What is NanoAct™ ?
NanoAct™, cellulose nano beads boasting remarkable color intensity,
significantly enhances assay sensitivity.
Why you Choose NanoAct™ for your test kit?
High Sensitivity
NanoAct™ enhances visibility and enables more sensitive detection of low antigen concentrations.
01. FluA/B Assay
Performance comparison between commercially available kits and Asahi Kasei prototype kits using NanoAct™ (n=1).
The horizontal axis represents the intensity of line color as determined by visual inspection.
The numerical values correspond to the reference grade table below.
The tested antigens are as follows:
(i) RayBiotech Influenza A Brisbane_10_07(H3N2)_8000-fold dilution
(ii) SIN 40205-V08 Influenza A H1N1 (A_California07_2009) Nucleorotein_50000-fold dilution
(iii) RayBiotech Influenza HA B Victoria_504_00_2000-fold dilution
(i) FluA 
(ii) FluA 
(iii) FluB 
Other Assays
hCG Assay
Troponin I Assay
*n=10 in each concentration
*Test Lines (after 15 minutes) were compared by reader (mV)
*Materials: antibodies, conjugate pads, nitrocellulose membranes, absorbent pads, and sample pads (hCG Assay), blood separation filters (Troponin I Assay)
Fast Detection Time
Enhanced test lines can be attained, resulting in expedited detection times.
*A comparative analysis reveals the performance distinction between two prototype test kits: one utilizing NanoAct™ (upper) and the other employing colloidal gold (lower).
When subjected to identical antibody concentrations, three minutes after sample addition, the test lines on the NanoAct™ kit exhibited enhanced visibility.
Multiple Colors
NanoAct™ offers you the potential to make your rapid test’s sensitivity higher. Also, it makes multiple target markers visually distinct by the use of its range of multiple colors.
Our Product
Conventional Product A
Conventional Product B
Information
Particle
Our Prototype: RE1AA for FluA, BL1AA for FluB, RE1CA for COVID-19
Product A：Colloidal Gold test kit
Product B：Latex Beads test kit
Antigen
Flu A : H3N2, Brisbane, 27.5 ng/mL
Flu B : Victoria, 50 ng/mL
COVID-19 : recombinant N-protein, 0.5 ng/mL
Notes
・Left: Positive, Right: Negative
・Our prototype doesn’t have CL.
・3 pathogens were tested at the same time.
・Testing Time: 10 min.
Case Study 1: Potential to Cost Saving
NanoAct™ offers the potential to lower antibody usage while maintaining the required sensitivity of your kit.
NanoAct™
Colloidal Gold
-Antibody Usage-
NanoAct™: 0.030μg/test、Colloidal gold: 0.280μg/test
-Antigen-
influenza B Austria, 5,000 TCID50/mL
Model Antibody Cost Comparison Study: NanoAct™ vs Colloidal Gold
*Tested by Artemis Dx
*Detail condition is described in white paper
Product Information
The results listed on this page are based on in-house data and do not guarantee the figures.